Key facts
- It has raised $1.4M; the latest was Early Stage VC ($1.4M) in Dec 2024.
- Notable investors include MOOC-CN Investment, Shanghai Angel Group.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Shuda Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shuda Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shuda Technology
Developer of pathology AI platform designed for diagnostic practices. The company develops a pathology image AI analysis system that is widely used in medical fields such as tumors, immune diseases, cardiovascular, nervous system, and endocrinology, also provides medical image AI diagnostic products and overall solutions for clinical institutions, enabling intelligent full-process pathology image analysis solutions for a wide range of medical workers and scientific researchers.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Shuda Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shuda Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shuda Technology in its N-PORT filings yet. We sweep new filings monthly.